NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.

Parenteral administration of Analgin is contraindicated in infants <1 year old.

Metamizole is banned in more than 30 countries, including Japan, Australia, the UK and the USA.